Cullen/Frost Bankers, Inc. Heron Therapeutics, Inc. Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
173Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$63.8 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$20.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$19.5 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$16.7 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $284M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...